Cargando…

Finding a way to preserve mitochondria: new pathogenic pathways in experimental multiple sclerosis

Detalles Bibliográficos
Autores principales:	Mancini, Andrea, Gaetani, Lorenzo, Gentili, Lucia, Di Filippo, Massimiliano
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2019
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6262986/ https://www.ncbi.nlm.nih.gov/pubmed/30531078 http://dx.doi.org/10.4103/1673-5374.243707

Ejemplares similares

Cognitive impairment in multiple sclerosis: lessons from cerebrospinal fluid biomarkers
por: Gaetani, Lorenzo, et al.
Publicado: (2020)

SARS-CoV-2 vaccines tolerability: A perspective by people with multiple sclerosis
por: Di Filippo, Massimiliano, et al.
Publicado: (2022)

Synaptic Dysfunction in Multiple Sclerosis: A Red Thread from Inflammation to Network Disconnection
por: Bellingacci, Laura, et al.
Publicado: (2021)

Host and Microbial Tryptophan Metabolic Profiling in Multiple Sclerosis
por: Gaetani, Lorenzo, et al.
Publicado: (2020)

Orexin/hypocretinin in multiple sclerosis and experimental autoimmune encephalomyelitis
por: Pallais, Jean Pierre, et al.
Publicado: (2019)

Finding Our Way through Phenotypes
por: Deans, Andrew R., et al.
Publicado: (2015)

Trauma care: Finding a better way
por: Alam, Hasan B.
Publicado: (2017)

Neuronal and endothelial transglutaminase-2 expression in experimental autoimmune encephalomyelitis and multiple sclerosis
por: Pearse, Damien D., et al.
Publicado: (2021)

Neuroprotective effects of vascular endothelial growth factor A in the experimental autoimmune encephalomyelitis model of multiple sclerosis
por: Lin, Wensheng
Publicado: (2017)

Finding the Right Way to Target EGFR in Glioblastomas; Lessons from Lung Adenocarcinomas
por: Gao, Ya, et al.
Publicado: (2018)

Drug repurposing for neuroregeneration in multiple sclerosis
por: Küry, Patrick, et al.
Publicado: (2018)

Targeting metabolism to treat multiple sclerosis
por: Bhargava, Pavan
Publicado: (2020)

Multiple sclerosis drug repurposing for neuroregeneration
por: Göttle, Peter, et al.
Publicado: (2023)

Haves and have nots must find a better way: The case for open scientific hardware
por: Maia Chagas, André
Publicado: (2018)

Multiple Sclerosis: Overview of Disease-Modifying Agents
por: Finkelsztejn, Alessandro
Publicado: (2014)

Perspectives on neuroreparative therapies for treating multiple sclerosis
por: Xiao, Junhua
Publicado: (2015)

Tremor in Multiple Sclerosis—An Overview and Future Perspectives
por: Makhoul, Karim, et al.
Publicado: (2020)

Immunological role of sulfatide in the pathogenesis of multiple sclerosis
por: Hamatani, Mio, et al.
Publicado: (2023)

Charles Darwin’s Mitochondria
por: Hayman, John
Publicado: (2013)

Ependymal cells and multiple sclerosis: proposing a relationship
por: Hatrock, Dale, et al.
Publicado: (2019)

Mitochondria take center stage
por: Sheu, Shey-Shing, et al.
Publicado: (2012)

Mitochondria in the context of Parkinson's disease
por: Villacé, Patricia, et al.
Publicado: (2017)

Focusing on caveolin-1 in CNS autoimmune disease: multiple sclerosis
por: Wu, Hao, et al.
Publicado: (2016)

Galectin-3 prospects as a therapeutic agent for multiple sclerosis
por: Thomas, Laura, et al.
Publicado: (2019)

Myelin positron emission tomography (PET) imaging in multiple sclerosis
por: de Paula Faria, Daniele
Publicado: (2020)

The Importance of the Cognitive Aspects of Vocational Rehabilitation for Individuals With Multiple Sclerosis
por: Kennedy, Winston, et al.
Publicado: (2020)

Brain network correlates of epilepsy occurrence in multiple sclerosis and neuroinflammation
por: Ciolac, Dumitru, et al.
Publicado: (2022)

Trans-synaptic degeneration as a mechanism of neurodegeneration in multiple sclerosis
por: Murphy, Olwen C., et al.
Publicado: (2023)

Non-steroidal anti-inflammatory drugs (NSAIDs) and neuroprotection in the elderly: a view from the mitochondria
por: Calvo-Rodríguez, María, et al.
Publicado: (2015)

An Overview of Experimental and Clinical Spinal Cord Findings in Alzheimer’s Disease
por: Xie, Qing, et al.
Publicado: (2019)

Persistent activation of microglia and NADPH drive hippocampal dysfunction in experimental multiple sclerosis
por: Di Filippo, Massimiliano, et al.
Publicado: (2016)

Miro—Working beyond Mitochondria and Microtubules
por: Tang, Bor Luen
Publicado: (2018)

Environmental enrichment as a promising strategy for aiding multiple sclerosis treatment
por: Silva, Berenice Anabel, et al.
Publicado: (2020)

Role of CD20(+) T cells in multiple sclerosis: implications for treatment with ocrelizumab
por: Gingele, Stefan, et al.
Publicado: (2019)

Editorial: Cognition in Multiple Sclerosis
por: Cortese, Rosa, et al.
Publicado: (2021)

Moss genetics and the way forward
por: Ashton, Neil
Publicado: (2018)

The role of mitochondria in the recovery of neurons after injury
por: McElroy, Taylor, et al.
Publicado: (2022)

Biochemical indicators for neuronal regeneration during intrathecal triamcinolone application in multiple sclerosis
por: Müller, Thomas, et al.
Publicado: (2015)

Pharmacological interventions targeting nuclear factor-kappa B signaling in multiple sclerosis
por: De Kleijn, Kim M. A., et al.
Publicado: (2021)

Multiple sclerosis: why we should focus on both sides of the (auto) antibody
por: den Dunnen, Jeroen, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_e8uod3t8eja5269qa63mggds53